Platelet-rich fibrin reduces pain and accelerates healing of oral ulcers in blistering skin diseases
Platelet-rich fibrin (PRF) provides rapid pain reduction and accelerated healing of oral ulcers and hence is superior compared to corticosteroids, says a study published in Wound Repair and Regeneration.
The study was conducted by Eman M. Ahmed, Faculty of Dentistry, Beni-Suef University, Beni-Suef, Egypt, and colleagues with the objective to evaluate the healing power of platelet-rich fibrin in terms of pain control and mucosal repair.
For this purpose, the researchers conducted a randomized, controlled, pilot clinical trial on 16 patients. They were randomly distributed with a 1:1 allocation ratio into two groups. The treatment group received PRF minced and mixed with orabase and the control group received clobetasol propionate 0.05% mixed with orabase.
The study led to the following findings:
- Pain reduction was evaluated as the primary outcome along with mucositis healing as the secondary outcome.
- A statistically significant difference in pain reduction was observed between the two groups.
- The clinical results on Day 7 have shown that the PRF group had 100% pain reduction while CP group had a 32.5% reduction from baseline.
The researchers conclude, "PRF offered superior clinical results providing rapid pain alleviation and accelerated ulcer healing compared to corticosteroids."
What is platelet-rich fibrin (PRF)?
Platelet-rich fibrin (PRF) is a fibrin matrix in which growth factors, platelet cytokines, and cells are trapped and may be released after a certain time and that can serve as a resorbable membrane. It accelerates the healing of soft and hard tissue and is used as a tissue-engineering scaffold for endodontics. For obtaining PRF, a required blood quantity is dawn quickly into test tubes without an anticoagulant and centrifuged immediately.
Reference:
Ahmed EM, Shafik S, El Saadany B. Platelet-rich fibrin a new approach in management of persistent oral ulcers in blistering skin diseases. Wound Repair Regen. 2022 May 19. doi: 10.1111/wrr.13020. Epub ahead of print. PMID: 35589608.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.